3-[(3S,5aR,6R,7R,8aS)-7-Hydroxy-6-[(E,3R)-3-hydroxy-4-phenoxy-but-1-enyl]-3,4,5,5a,6,7,8,8a-octahydro-2H-cyclopenta[b]oxepin-3-yl]propanoic acid

ID: ALA3984438

PubChem CID: 134157766

Max Phase: Preclinical

Molecular Formula: C22H30O6

Molecular Weight: 390.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CC[C@@H]1CC[C@@H]2[C@@H](/C=C/[C@@H](O)COc3ccccc3)[C@H](O)C[C@@H]2OC1

Standard InChI:  InChI=1S/C22H30O6/c23-16(14-27-17-4-2-1-3-5-17)8-10-18-19-9-6-15(7-11-22(25)26)13-28-21(19)12-20(18)24/h1-5,8,10,15-16,18-21,23-24H,6-7,9,11-14H2,(H,25,26)/b10-8+/t15-,16+,18+,19+,20+,21-/m0/s1

Standard InChI Key:  IYVIISGTDLLJJD-UWXHIMLYSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
    1.8403  -15.6909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3564  -16.3338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1226  -16.0396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8043  -16.4856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5334  -16.1163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2192  -16.5664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9483  -16.1971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1717  -17.3817    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1401  -17.1203    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6341  -16.6431    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6252  -17.4579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9144  -17.8589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9091  -18.6725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6125  -19.0847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3234  -18.6784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3276  -17.8668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7481  -14.7214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7567  -13.8704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1227  -13.3669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0855  -15.2233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2895  -15.0045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9488  -14.2154    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3246  -13.5183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3209  -12.5736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1060  -12.3497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3042  -11.5564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0861  -11.3235    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7141  -10.9861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7905  -15.6319    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.4980  -14.7954    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
 21  1  1  0
  1  2  1  0
  2  3  1  0
  3 20  1  0
  3  4  1  1
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  1  6
  2  9  1  6
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 17 18  1  0
 18 19  1  0
 20 17  1  0
 21 22  1  0
 22 23  1  0
 23 19  1  0
 20 21  1  0
 19 24  1  6
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 20 29  1  1
 21 30  1  1
M  END

Alternative Forms

  1. Parent:

    ALA3984438

    ---

Associated Targets(Human)

PTGFR Tclin Prostanoid FP receptor (687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGER3 Tclin Prostanoid EP3 receptor (1985 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGIR Tclin Prostanoid IP receptor (1280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.48Molecular Weight (Monoisotopic): 390.2042AlogP: 2.64#Rotatable Bonds: 8
Polar Surface Area: 96.22Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 4.44CX Basic pKa: CX LogP: 2.05CX LogD: -0.81
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: 1.01

References

1. Sugimoto I, Kambe T, Okino T, Obitsu T, Ohta N, Nishiyama T, Kinoshita A, Fujimoto T, Egashira H, Yamane S, Shuto S, Tani K, Maruyama T..  (2017)  Discovery of Novel Seven-Membered Prostacyclin Analogues as Potent and Selective Prostaglandin FP and EP3 Dual Agonists.,  (1): [PMID:28105284] [10.1021/acsmedchemlett.6b00415]

Source